There is little time left for TransCode Therapeutics Inc (RNAZ) to reach its 1-year target estimate. How soon will it surpass it?
TransCode Therapeutics Inc (NASDAQ:RNAZ) shares traded 2.86% higher at $0.37 on Wall Street last session. In accordance with the data, 1 analysts cover TransCode Therapeutics Inc (NASDAQ:RNAZ). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $3.00, […]
Does TransCode Therapeutics Inc (NASDAQ:RNAZ) presents a BIG investment opportunity?
Stocks of TransCode Therapeutics Inc (NASDAQ:RNAZ) traded higher last session on Wall Street, down -13.72% to $0.37. According to the data, TransCode Therapeutics Inc (NASDAQ:RNAZ) has 1 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 and […]
An overview of TransCode Therapeutics Inc’s (RNAZ) institutional holdings
The price of TransCode Therapeutics Inc (NASDAQ:RNAZ) shares last traded on Wall Street fell -72.91% to $0.69. Based on available information, 1 analysts follow TransCode Therapeutics Inc (NASDAQ:RNAZ). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $12.00 and a low of […]
